Literature DB >> 25061118

Misuse of benzodiazepines and Z-drugs in the UK.

V Kapil1, J L Green1, C Le Lait1, D M Wood1, P I Dargan1.   

Abstract

Benzodiazepines and Z-drugs are commonly prescribed for insomnia and anxiety syndromes and there is increasing concern regarding their misuse. Using an internet-based questionnaire we found that of 1500 respondents 7.7% (n = 116) had misused one or more of these medications. Almost 15% of those misusing at least one of these drugs did so once weekly or more often. The main reasons reported for their use were to help sleep (66.4%), to cope with stress (37.1%) and/or to get high (31.0%). A total of 31% obtained the medications from multiple sources; healthcare professionals (55.2%) and friends/family (39.7%) most commonly. Our study can be used to inform prevention measures for their misuse. Royal College of Psychiatrists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25061118     DOI: 10.1192/bjp.bp.114.149252

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  17 in total

1.  Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected].

Authors:  James Davies; Todd C Rae; Luke Montagu
Journal:  Br J Gen Pract       Date:  2017-07-17       Impact factor: 5.386

2.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

3.  Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis.

Authors:  Louis Jacob; Michael A Rapp; Karel Kostev
Journal:  Ther Adv Psychopharmacol       Date:  2017-03-01

Review 4.  Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Taro Kishi; Shinji Matsunaga; Nakao Iwata
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-06-18       Impact factor: 5.270

5.  Evaluation of Risk Factors Associated to Prescription of Benzodiazepines and its Patterns in a Cohort of Patients from Mental Health: A Real World Study in Spain.

Authors:  Jorge Simal-Aguado; María-Pilar Campos-Navarro; Francisco Valdivia-Muñoz; Alejandro Galindo-Tovar; Juan Antonio García-Carmona
Journal:  Psychopharmacol Bull       Date:  2021-01-12

Review 6.  Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis.

Authors:  Karen Donnelly; Robert Bracchi; Jonathan Hewitt; Philip A Routledge; Ben Carter
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

7.  Inpatient Z-drug use commonly exceeds safe dosing recommendations.

Authors:  Todd C Lee; André Bonnici; Robyn Tamblyn; Emily G McDonald
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

8.  Presentations to an urban emergency department in Bern, Switzerland associated with acute recreational drug toxicity.

Authors:  Evangelia Liakoni; Sabine Müller; Adrian Stoller; Meret Ricklin; Matthias E Liechti; Aristomenis K Exadaktylos
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-03-07       Impact factor: 2.953

9.  Tackling benzodiazepine misuse.

Authors:  Benedict Hayhoe; James Lee-Davey
Journal:  BMJ       Date:  2018-07-27

10.  Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.

Authors:  Evangelia Liakoni; Patrick C Dolder; Katharina M Rentsch; Matthias E Liechti
Journal:  BMC Pharmacol Toxicol       Date:  2016-05-26       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.